Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT before expanding Australia-wide.
Proteomics International Laboratories’ PromarkerD blood test has proven to be a step up in predicting chronic kidney disease in a WA-based study of diabetes patients.
Proteomics International Laboratories can roll out its novel diabetes-related blood test in the US,having received certification for its Californian reference lab.
A Proteomics International subsidiary has unveiled a novel fingerprick test to track muscle damage in elite runners,transforming recovery and performance management in athletes.
Proteomics International soared 24pc to 75c on news its PromarkerEndo test could successfully diagnose all stages of endometriosis,which affects 10pc of women.
Proteomics International Laboratories has boosted its fight against a deadly form of cancer after its blood test showed a detection accuracy of 94 per cent.
Proteomics International Laboratories has hired industry veteran Dr James Williams to help guide it towards commercialising its predictive diagnostics tools.
Proteomics International Laboratories’ “PromarkerD” testing has shown a high accuracy in predicting future kidney disease in type 1 diabetes patients.